Injective Price Prediction: INJ could rise 15% with multiple on-chain metrics in alignment

Source Fxstreet
  • Injective price V-shaped recovery has seen it overcome the 50-day SMA at $36.39.
  • INJ could extend the climb 20% to collect sell-side liquidity with technicals and on-chain metrics in support.
  • The bullish thesis will be invalidated upon a break and close below $34.09.

Injective (INJ) price is in a recovery mode after a steep rejection from the $43.51 blockade that sent the AI crypto coin down nearly 30%. This time, however, the climb is steered by bullish technical as well as on-chain fundamentals, increasing the upside potential for INJ.

Also Read: Injective Price Prediction: Volan Mainnet Upgrade fails to catalyze recovery after 20% slump

Injective price eyes 15% gains

Injective (INJ) price could rise 15% to tag the $43.51 resistance level, with technical indicators flashing bullish. For one, the 50-, 100-, and 200-day Simple Moving Averages (SMAs) provide downward support at $36.39, $26.13, and $16.88 levels respectively, while pointing north to show this is the path with the least resistance.

The Relative Strength Index (RSI) is also inclined north, suggesting rising momentum after calling a signal to buy INJ when it crossed above the signal line. Traders heeding this call would enhance the climb for Injective price.

Further, the Moving Average Convergence Divergence (MACD) indicator is also teasing with a bullish crossover, accentuated by green histogram bars on the Awesome Oscillator. These add credence to the bullish thesis.

Enhanced buying pressure among the bulls could see Injective price make the 15% climb to the $43.51 barricade. In a highly bullish case, the gains could extend for the price to reclaim the range high at $45.30, potentially clearing as it reaches for the $50.00 psychological level.

INJ/USDT 1-day chart

On-chain metrics supporting bullish outlook for Injective price

On-chain metrics from Santiment support the bullish thesis. To start with, the social dominance of the AI crypto coin is rising, representing more levels of mentions of the INJ token across a pool of crypto-related social media.

INJ Santiment: Social dominance

There is also a significant rise in exchange outflow, reducing the effective short-term sell pressure on Injective price. This is accentuated by the supply on exchanges as a percentage of total supply, which appears subdued, moving horizontally at $-0.76 to show reducing sell pressure.

INJ Santiment: Exchange outflow, Supply on exchanges 

On the other hand, if traders give in to their profit appetite and prematurely cash in on the gains made, Injective price could pull south, slipping below the 50-day SMA to retest the $34.00 support. A break and close below this level would invalidate the bullish thesis, with Injective price likely to extend the fall to the $31.00 psychological level.  

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Markets in 2026: Will gold, Bitcoin, and the U.S. dollar make history again? — These are how leading institutions thinkAfter a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
Author  Insights
Dec 25, Thu
After a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
placeholder
ECB Policy Outlook for 2026: What It Could Mean for the Euro’s Next MoveWith the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
Author  Mitrade
Dec 26, Fri
With the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
placeholder
Two Crypto “Buy” Calls for 2027: Bitcoin Looks Plausible, XRP Looks Like a High-Conviction BetStandard Chartered’s Kendrick-backed 2027 targets paint large upside for Bitcoin and XRP—but Bitcoin’s ETF-led adoption case looks sturdier, while XRP remains a higher-volatility bet dependent on ETF traction and real-world payments scaling.
Author  Mitrade
Yesterday 09: 39
Standard Chartered’s Kendrick-backed 2027 targets paint large upside for Bitcoin and XRP—but Bitcoin’s ETF-led adoption case looks sturdier, while XRP remains a higher-volatility bet dependent on ETF traction and real-world payments scaling.
placeholder
Silver Price Forecasts: XAG/USD drops below $75.00 after Trump - Zelenkyy’s meeting Silver (XAG/USD) has lost more than $10 since hitting a fresh record high near $86.00 on Monday’s early trading. The precious metal has retreated to levels in the $74.00 area at the time of writing, weighed by comments by US President Trump about the chances of a peace deal in Ukraine.
Author  FXStreet
Yesterday 09: 42
Silver (XAG/USD) has lost more than $10 since hitting a fresh record high near $86.00 on Monday’s early trading. The precious metal has retreated to levels in the $74.00 area at the time of writing, weighed by comments by US President Trump about the chances of a peace deal in Ukraine.
placeholder
Ethereum smart contract deployments reach new 8.7M high in Q4Token Terminal data revealed that smart contracts deployed on the Ethereum network hit an all-time high of 8.7 million in the fourth quarter of 2025.
Author  Cryptopolitan
Yesterday 09: 42
Token Terminal data revealed that smart contracts deployed on the Ethereum network hit an all-time high of 8.7 million in the fourth quarter of 2025.
goTop
quote